Vifor Pharma Ltd., 10% Owner at ChemoCentryx, Inc. (CCXI), sold 379,917 shares at $55.44 ($21.2M) on 2020-07-21, disclosed to the SEC on 2020-07-21.
Open-market sale of $21.2M CCXI by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $55.23 | 25,577 | $1.4M | 6.7% |
| 2 | $55.23 | 25,577 | $1.4M | 6.7% |
| 3 | $56.58 | 22,196 | $1.3M | 5.9% |
| 4 | $56.58 | 22,196 | $1.3M | 5.9% |
| 5 | $57.03 | 117 | $7K | 0.0% |
| 6 | $55.70 | 17,002 |
| $947K |
| 4.5% |
| 7 | $55.70 | 17,002 | $947K | 4.5% |
| 8 | $56.18 | 37,596 | $2.1M | 10.0% |
| 9 | $56.18 | 37,596 | $2.1M | 10.0% |
| 10 | $55.44 | 81,266 | $4.5M | 21.3% |
| 11 | $55.44 | 81,266 | $4.5M | 21.3% |
| 12 | $56.20 | 6,263 | $352K | 1.7% |
| 13 | $56.20 | 6,263 | $352K | 1.7% |
| Total | $55.74 avg | 379,917 | $21.2M | 100% |